ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 87 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,208,000 | – | 110,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,399,034 | $49,422,000 | 10.17% |
| VR Adviser, LLC | 4,563,962 | $66,360,000 | 9.07% |
| COMMODORE CAPITAL LP | 2,672,346 | $38,856,000 | 9.00% |
| TCG Crossover Management, LLC | 1,082,213 | $15,735,000 | 7.37% |
| Foresite Capital Management V, LLC | 1,258,243 | $18,295,000 | 4.50% |
| Parkman Healthcare Partners LLC | 1,025,522 | $14,911,000 | 3.29% |
| Aisling Capital Management LP | 634,455 | $9,225,000 | 3.25% |
| GREAT POINT PARTNERS LLC | 800,000 | $11,632,000 | 2.58% |
| Samsara BioCapital, LLC | 794,171 | $11,547,000 | 2.24% |
| Affinity Asset Advisors, LLC | 400,000 | $5,816,000 | 2.11% |